The impact of COVID-19 on global tuberculosis control.
作者信息
Lipman Marc, McQuaid C Finn, Abubakar Ibrahim, Khan Mishal, Kranzer Katharina, McHugh Timothy D, Padmapriyadarsini Chandrasekaran, Rangaka Molebogeng X, Stoker Neil
机构信息
UCL Respiratory, Division of Medicine, Royal Free Campus University College London; Respiratory Medicine Royal Free London NHS Foundation Trust, UK.
Department of Infectious Disease Epidemiology, TB Modelling Group, TB Centre & Centre for Mathematical Modelling of Infectious Diseases, Faculty of Epidemiology & Population Health, UK.
出版信息
Indian J Med Res. 2021 Apr;153(4):404-408. doi: 10.4103/ijmr.IJMR_326_21.
Abstract
摘要
相似文献
1
The impact of COVID-19 on global tuberculosis control.
Indian J Med Res. 2021 Apr;153(4):404-408. doi: 10.4103/ijmr.IJMR_326_21.
2
Impact of COVID-19 on tuberculosis control in China.
Int J Tuberc Lung Dis. 2020 May 1;24(5):545-547. doi: 10.5588/ijtld.20.0127.
3
Dismal global tuberculosis situation due to COVID-19.
Lancet Infect Dis. 2021 Dec;21(12):1636. doi: 10.1016/S1473-3099(21)00713-1.
4
COVID-19 and Tuberculosis overlapping epidemics: A holistic review from Pakistan.
J Med Virol. 2021 May;93(5):2573-2575. doi: 10.1002/jmv.26714. Epub 2021 Feb 23.
5
Getting back on the road towards tuberculosis elimination: lessons learnt from the COVID-19 pandemic.
J Bras Pneumol. 2021 Apr 30;47(2):e20210123. doi: 10.36416/1806-3756/e20210123.
6
COVID-19 & the National Tuberculosis Elimination Programme of India.
Indian J Med Res. 2021 May;153(5&6):533-536. doi: 10.4103/ijmr.IJMR_2763_20.
7
Tuberculosis Elimination in the Era of Coronavirus Disease 2019 (COVID-19): A Moving Target.
Clin Infect Dis. 2022 Feb 11;74(3):509-510. doi: 10.1093/cid/ciaa1400.
8
COVID 19 and tuberculosis.
Indian J Tuberc. 2020 Apr;67(2):149-151. doi: 10.1016/j.ijtb.2020.06.001.
9
How TB and COVID-19 compare: an opportunity to integrate both control programmes.
Int J Tuberc Lung Dis. 2020 Sep 1;24(9):971-974. doi: 10.5588/ijtld.20.0417.
10
Perspective of Covid-19 pandemic in South Asian countries.
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13098-13100. doi: 10.26355/eurrev_202012_24217.
引用本文的文献
1
The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020-2023.
PLOS Glob Public Health. 2024 Jul 3;4(7):e0003043. doi: 10.1371/journal.pgph.0003043. eCollection 2024.
2
Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE).
BMC Infect Dis. 2024 Jan 19;24(1):107. doi: 10.1186/s12879-023-08876-8.
3
Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community.
Thorax. 2024 Mar 15;79(4):325-331. doi: 10.1136/thorax-2023-220047.
4
Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity.
J Med Chem. 2023 Nov 23;66(22):15380-15408. doi: 10.1021/acs.jmedchem.3c01514. Epub 2023 Nov 10.
5
Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.
Int J Mol Sci. 2023 Apr 18;24(8):7439. doi: 10.3390/ijms24087439.
6
Snakebite care through the first two waves of COVID-19 in West Bengal, India: a qualitative study.
Toxicon X. 2023 Jun;18:100157. doi: 10.1016/j.toxcx.2023.100157. Epub 2023 Apr 12.
本文引用的文献
1
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
N Engl J Med. 2021 Jul 8;385(2):187-189. doi: 10.1056/NEJMc2104974. Epub 2021 May 5.
2
Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries.
PLoS One. 2021 Feb 2;16(2):e0244936. doi: 10.1371/journal.pone.0244936. eCollection 2021.
3
COVID-19 -Tuberculosis interactions: When dark forces collide.
Indian J Tuberc. 2020 Dec;67(4S):S155-S162. doi: 10.1016/j.ijtb.2020.07.003. Epub 2020 Jul 15.
4
The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India.
Indian J Tuberc. 2020 Dec;67(4S):S139-S146. doi: 10.1016/j.ijtb.2020.07.004. Epub 2020 Jul 10.
5
India's syndemic of tuberculosis and COVID-19.
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-003979.
6
The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis.
EClinicalMedicine. 2020 Oct 24;28:100603. doi: 10.1016/j.eclinm.2020.100603. eCollection 2020 Nov.
7
Adapting TB services during the COVID-19 pandemic in Mumbai, India.
Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1119-1121. doi: 10.5588/ijtld.20.0537.
8
The potential impact of COVID-19-related disruption on tuberculosis burden.
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.01718-2020. Print 2020 Aug.
9
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.
Ann Clin Microbiol Antimicrob. 2020 May 23;19(1):21. doi: 10.1186/s12941-020-00363-1.
10
Protecting households from catastrophic health spending.
Health Aff (Millwood). 2007 Jul-Aug;26(4):972-83. doi: 10.1377/hlthaff.26.4.972.
Zotero 插件